Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Qualigen Therapeutics Inc
(QLGN)
:QLGN
QLGN
Qualigen Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Qualigen Therapeutics (QLGN) Price & Analysis
Compare
Follow
715
Followers
QLGN Stock Chart & Stats
$2.88
-$0.19
(-4.32%)
At close:
Jan 08
4:00 PM EST
$2.88
-$0.19
(-4.32%)
1d
5d
3m
20.20%
6m
YTD
1y
3y
5y
Day’s Range
― - ―
52-Week Range
― - ―
Previous Close
N/A
Volume
8.82K
Average Volume (3M)
N/A
Market Cap
N/A
Enterprise Value
N/A
Total Cash (Recent Filing)
$38.78M
Total Debt (Recent Filing)
$3.24M
Price to Earnings (P/E)
―
Beta
N/A
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A
Share Statistics
EPS (TTM)
-55.30
Shares Outstanding
N/A
10 Day Avg. Volume
N/A
30 Day Avg. Volume
N/A
Financial Highlights & Ratios
PEG Ratio
>-0.01
Price to Book (P/B)
0.57
Price to Sales (P/S)
0.00
P/FCF Ratio
-0.24
Enterprise Value/Market Cap
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/Gross Profit
N/A
Enterprise Value/Ebitda
0.00
Forecast
1Y Price Target
N/A
Price Target Upside
N/A
Rating Consensus
N/A
Number of Analyst Covering
0
EPS Forecast (FY)
N/A
Revenue Forecast (FY)
N/A
Show More
Qualigen Therapeutics News
Qualigen Therapeutics stockholders approve all proposals with majority vote
27d ago
FFAI
QLGN
Qualigen Therapeutics Rebrands to AIxCrypto Holdings
26d ago
8K
QLGN
Qualigen Therapeutics to rebrand as AIxCrypto
2M ago
FFAI
QLGN
Why Is Qualigen Stock (QLGN) Exploding Today? Crypto Deal Sparks the Rally
2M ago
QLGN
Qualigen Therapeutics partners with BitGo to execute C10 treasury allocation
2M ago
QLGN
Qualigen Therapeutics Secures $41M for Crypto Transformation
2M ago
8K
QLGN
Qualigen Therapeutics closes $41M PIPE financing led by Faraday Future
2M ago
FFAI
QLGN
Qualigen Therapeutics Announces $41M Private Placement
3M ago
8K
QLGN
Crypto Currents: BitGo files for IPO as companies pivot to crypto
3M ago
BK
TM
Faraday Future announces investment of $41M in Qualigen
3M ago
FFAI
QLGN
Faraday Future announces $41M investment in Qualigen Therapeutics
3M ago
FFAI
QLGN
Qualigen Therapeutics files to sell 3.21M shares of common stock for holders
3M ago
QLGN
Qualigen Therapeutics Amends Promissory Note with Marizyme
3M ago
8K
QLGN
Qualigen Therapeutics Granted Nasdaq Compliance Extension
3M ago
8K
QLGN
Show More
QLGN FAQ
What was Qualigen Therapeutics Inc’s price range in the past 12 months?
Currently, no data Available
What is Qualigen Therapeutics Inc’s market cap?
Currently, no data Available
When is Qualigen Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qualigen Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Qualigen Therapeutics Inc overvalued?
According to Wall Street analysts Qualigen Therapeutics Inc’s price is currently Overvalued.
Get more investment ideas with TipRanks Premium
Does Qualigen Therapeutics Inc pay dividends?
Qualigen Therapeutics Inc does not currently pay dividends.
What is Qualigen Therapeutics Inc’s EPS estimate?
Qualigen Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qualigen Therapeutics Inc have?
Currently, no data Available
What happened to Qualigen Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qualigen Therapeutics Inc?
Currently, no hedge funds are holding shares in QLGN
Qualigen Therapeutics (QLGN) Earnings & Revenues
Earnings
Revenues
Historic Earnings Reports
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Overall Consensus
Strong Sell
3
Bullish
4
Neutral
15
Bearish
Bullish
Neutral
Bearish
Overall Consensus
3
4
15
Technical Analysis
3
4
3
Moving Averages
0
0
12
Technical Analysis >
Similar Stocks
Company
Price & Change
Follow
ERNA
Eterna Therapeutics
―
―
XBIO
Xenetic Biosciences
―
―
VYNE
VYNE Therapeutics
―
―
GNPX
Genprex
―
―
INAB
IN8bio
―
―
Compare QLGN Stocks >
Ownership Overview
0.22%
0.01%
99.76%
―
Insiders
0.22%
Mutual Funds
0.01% Other Institutional Investors
99.76% Public Companies and
Individual Investors
Detailed Ownership Overview >
Options Prices
Currently, No data available
---
Popular Stocks
You need to enable JavaScript to run this app.